Prospective Multiethnic Validation of the Behçet's Syndrome Overall Damage Index (BODI)

Active, not recruitingOBSERVATIONAL
Enrollment

970

Participants

Timeline

Start Date

July 23, 2021

Primary Completion Date

December 30, 2027

Study Completion Date

December 30, 2027

Conditions
Behçet's Syndrome (BS)
Trial Locations (1)

09042

Rheumatology Unit, University and AOU of Cagliari, Monserrato

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Hôpital de Hautepierre

OTHER

collaborator

University of Siena

OTHER

collaborator

Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Universitat de Barcelona, Barcelona, Spain.

UNKNOWN

collaborator

Università degli Studi di Ferrara

OTHER

collaborator

Tabriz University of Medical Sciences

OTHER

collaborator

University of Bari

OTHER

collaborator

Cairo University

OTHER

collaborator

Tehran University of Medical Sciences

OTHER

collaborator

Ibn Sina University Hospital, Rabat, Morocco

OTHER

collaborator

Istanbul University

OTHER

collaborator

Nazarbayev University School of Medicine

UNKNOWN

collaborator

Aristotle University Of Thessaloniki

OTHER

collaborator

Mayo Clinic

OTHER

collaborator

Centro Hospitalar do Porto

OTHER

collaborator

Centro Hospitalar do Tâmega e Sousa

OTHER

collaborator

Federal University of São Paulo

OTHER

lead

University of Cagliari

OTHER

NCT07073261 - Prospective Multiethnic Validation of the Behçet's Syndrome Overall Damage Index (BODI) | Biotech Hunter | Biotech Hunter